天邑股份经营极速萎缩，专利减少却“蒙眼”称增多？ | 看财报

Core Viewpoint - Tianyi Co., Ltd. reported significant losses in its latest financial results, leading to a sharp decline in stock price, primarily due to a 36.45% year-on-year drop in revenue and a net profit loss of 41.71 million yuan, marking a 224.95% decline compared to the previous year [2][3][7]. Financial Performance - In the first half of 2023, Tianyi Co., Ltd. achieved revenue of 669 million yuan, a decrease of 36.45% year-on-year [2][7]. - The net profit attributable to shareholders was -41.71 million yuan, down 224.95% year-on-year, while the non-recurring net profit was -47.63 million yuan, a decline of 231.38% [2][7]. - The company's revenue for 2023, 2024, and the first half of 2025 was 2.55 billion yuan, 1.77 billion yuan, and 670 million yuan, respectively, reflecting year-on-year changes of -14.64%, -30.81%, and -36.45% [7]. Product Performance - The main product, broadband network terminal equipment, saw a drastic decline in production and sales, with production at 4.47 million units and sales at 5.41 million units in the first half of 2025, generating revenue of 580 million yuan and a gross margin of only 9.54% [5][6]. - The overall production capacity utilization rate for broadband network terminal equipment was only 44.75% in the first half of 2025 [6]. Industry Context - The telecommunications industry showed steady growth, with total telecom business revenue reaching 905.5 billion yuan in the first half of 2023, a year-on-year increase of 1% [4]. - Despite industry growth, competition has intensified, leading to price and sales declines for Tianyi Co., Ltd.'s products [4][5]. Research and Development - The company has reduced its R&D investment, with expenditures dropping to 41.55 million yuan in the first half of 2025, a decrease of 11.34% year-on-year [8]. - The number of R&D personnel has also decreased significantly, from 462 in 2021 to 296 in 2024 [8]. - As of June 30, 2025, the company reported 356 valid patents, including 267 invention patents, indicating some progress in core R&D despite reduced investment [9]. Patent Discrepancies - There is a notable inconsistency in patent data reported by the company, with a claim of 372 valid patents at the end of 2024, which contradicts the 356 reported in mid-2025 [11][12]. - The company has not disclosed any information regarding potential patent expirations or losses, raising concerns about transparency [13].